Mechanism of Anti-Cancer Therapy Alopecia: An Achievement
Editorial Comment by Dr. Vatsul Sharma, Editor-in-Chief, International Healthcare Research Journal (IHRJ)
Choi EK, Kim IR, Chang O, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 2014;23:1103.
Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 2008;17:317.
Hesketh PJ, Batchelor D, Golant M, et al. Chemotherapy - Induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 2004; 12:543.
Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, Park G, Mitchel J, Bågeman E, D’Agostino RB et al. Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA 2017; 317: 606–14.
Marks DH, Qureshi A, Friedman A. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review. JAMA Dermatol. 2018;154(12):1465-72. doi: 10.1001/jamadermatol.2018.3465.
Purba TS, Ng'andu K, Brunken L, Smart E, Mitchell E et al. CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia. EMBO Mol Med. 2019;11(10):e11031